Research Groups

Neurogenetics and Molecular Medicine


Coordinators of the group

  • Janet Hoenicka
  • Francesc Palau Martínez

The group of "Neurogenetics and Molecular Medicine" (NeuroGene) investigates the molecular basis of development diseases and how the central and peripheral nervous systems work. The experimental approach includes genetic and genomic analyses, the cell biology and the study of the pathophysiology using animal models.

The "NeuroGene" scientific work has the vocation of clinical translation within the Pediatric Institute for Rare Diseases (IPER) and transfers the knowledge generated to the National Health System.

The group's strategy is based on three fundamental aspects of the research activity:

  1. Making science focused on one knowledge area, specifically in the area of ​​neurological and mental illnesses.
  2. Develop scientific lines that combine established knowledge with novel and risky hypothesis under frontier science.
  3. Develop a translational research model and biomedical innovation in the field of rare diseases based on the research about proposals or clinical hypotheses, and implement diagnostic and therapeutic services as instruments of the clinical translational and the interactions  with biomedical industry.

Research lines:

  • Genetics and pathophysiology of neuropsychiatric disorders (Parkinson's disease, addictive disorders) - Leader: Dr. Janet Hoenicka.
  • Genetics and pathophysiology of neuromuscular diseases (Charcot-Marie-Tooth neuropathy disease, Friedreich's ataxia) and neurodevelopmental diseases (Menkes disease, intellectual disability) - Leader: Dr. Francesc Palau
  • Genetics and pathophysiology of Rett Syndrome - Leader: Dr. Judith Armstrong